
Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity
Keywords: ADCC; antibody-dependent cellular cytotoxicity; C2B8; rituximab; CDC; complement-dependent cytotoxicity; CHO; chinese hamster ovary; FCM; flow cytometry; FITC; fluorescein isothiocyanate; mAb; monoclonal antibody; PBMC; peripheral blood mononuclear cells;